Atrium Therapeutics Inc (RNA)
Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 382,517 | 350,158 | 243,907 | 254,203 | 219,868 |
| Marketable Securities | 1,314,352 | 1,525,678 | 939,237 | 1,125,674 | 1,281,629 |
| Other current assets | 101,598 | 90,181 | 67,416 | 55,098 | 40,793 |
| TOTAL | $1,798,467 | $1,966,017 | $1,250,560 | $1,434,975 | $1,542,290 |
| Non-Current Assets | |||||
| PPE Net | 35,114 | 31,951 | 30,131 | 24,419 | 20,667 |
| TOTAL | $35,114 | $31,951 | $30,131 | $24,419 | $20,667 |
| Total Assets | $1,958,050 | $2,134,209 | $1,368,926 | $1,459,075 | $1,563,895 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $195,446 | $169,879 | $135,061 | $84,865 | $98,018 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $269,450 | $247,944 | $176,262 | $130,352 | $138,936 |
| Shareholders' Equity | |||||
| Retained earnings | -1,577,697 | -1,340,596 | -1,166,154 | -1,008,839 | -893,066 |
| Other shareholders' equity | 3,266,297 | 3,226,861 | 2,358,818 | 2,337,562 | 2,318,025 |
| TOTAL | $1,688,600 | $1,886,265 | $1,192,664 | $1,328,723 | $1,424,959 |
| Total Liabilities And Equity | $1,958,050 | $2,134,209 | $1,368,926 | $1,459,075 | $1,563,895 |